Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant group » significant gap (Expand Search), significant amount (Expand Search), significant genes (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
significant group » significant gap (Expand Search), significant amount (Expand Search), significant genes (Expand Search)
-
2841
The effect of CRNN downregulation on migration and invasion ability in cSCC cells.
Published 2024Subjects: -
2842
-
2843
-
2844
-
2845
-
2846
CONSORT diagram.
Published 2024“…The overall proportion of patients who experienced any adverse events was 57.8% in the GDFT group and 70.1% in the conventional group (P = 0.038), of which the occurrence of pleural effusion was significantly lower in the GDFT group than in the conventional group (9.5% vs. 19.7%; P = 0.024). …”
-
2847
Raw data.
Published 2024“…The overall proportion of patients who experienced any adverse events was 57.8% in the GDFT group and 70.1% in the conventional group (P = 0.038), of which the occurrence of pleural effusion was significantly lower in the GDFT group than in the conventional group (9.5% vs. 19.7%; P = 0.024). …”
-
2848
Postoperative outcomes.
Published 2024“…The overall proportion of patients who experienced any adverse events was 57.8% in the GDFT group and 70.1% in the conventional group (P = 0.038), of which the occurrence of pleural effusion was significantly lower in the GDFT group than in the conventional group (9.5% vs. 19.7%; P = 0.024). …”
-
2849
Postoperative complications.
Published 2024“…The overall proportion of patients who experienced any adverse events was 57.8% in the GDFT group and 70.1% in the conventional group (P = 0.038), of which the occurrence of pleural effusion was significantly lower in the GDFT group than in the conventional group (9.5% vs. 19.7%; P = 0.024). …”
-
2850
Growth of certain cancer cell lines requires IRE1 but not its enzymatic activity.
Published 2025Subjects: -
2851
-
2852
-
2853
-
2854
-
2855
-
2856
-
2857
-
2858
-
2859
-
2860